Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Techmind Financial Services | Other 28 Nov 2024 | | |
 | Founders Future Software Development | Other 3 Dec 2024 | | |
 | Galion.exe it services | Other 29 Nov 2024 | | |
 | Kickston Financial Services | Other 12 Nov 2024 | | |
 | baby vc Venture Capital and Private Equity Principals | Other 25 Oct 2024 | | |
 | CSL Biotechnology Research | Other 3 Oct 2024 | | |
 | iii - financements Financial Services | Other 16 Sep 2024 | | |
 | UroMems healthtech, biotech, deeptech | Other 28 Sep 2024 | | |
 | Paris Saclay Cancer Cluster (PSCC) Non-profit Organizations, healthtech, deeptech | Other 1 Oct 2024 | | |
 | PANTERA biotech, deeptech | Other 29 Nov 2024 | | |